Michael J. Wagner

Also affiliated with Dana-Farber Cancer Institute, Clinical Research Management

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.140Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Demographics, outcomes, and risk factors for patients (Pts) with sarcoma and COVID-19: A multi-institutional cohort analysis.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11523

Top 71%

0.140DataRank

Top 71%1 citations

Matthew Ingham, Corrie Painter, Rashmi Chugh, Jonathan C. Trent, Vivek Subbiah +15 more

Papers

Driven by 14 papers — median percentile 15. Top paper: “Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells”.

Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4239

N/A

1.4DataRank · unranked

46 citations

Laura Riolobos, Bonnie LaFleur, Matthew B. Spraker, Yongwoo David Seo, Kimberly S. Smythe +24 more

Combined VEGFR and MAPK pathway inhibition in angiosarcoma

Scientific Reports(2021)10.1038/s41598-021-88703-9

N/A

0.533DataRank · unranked

34 citations

Yasmin A. Lyons, Jean Siedel, Robert Dood, Archana S. Nagaraja, Monika Haemmerle +8 more

Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study

Cancers(2022)10.3390/cancers14174334

N/A

0.269DataRank · unranked

5 citations

Cassandra Hennessy, Alicia Beeghly, Benjamin French, Dimpy P. Shah, Sarah Croessmann +42 more

Demographics, outcomes, and risk factors for patients (Pts) with sarcoma and COVID-19: A multi-institutional cohort analysis.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11523

Top 71%

0.140DataRank

Top 71%1 citations

Matthew Ingham, Corrie Painter, Rashmi Chugh, Jonathan C. Trent, Vivek Subbiah +15 more

A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma

Cancers(2023)10.3390/cancers15092617

N/A

0DataRank · unranked

17 citations

Hilary Dietz, Sheima Farag, Angela C. Hirbe, Michael J. Wagner, Brian A. Van Tine +5 more

A multicenter phase II study of cabozantinib + nivolumab for patients (pts) with advanced angiosarcoma (AS) previously treated with a taxane (Alliance A091902).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11503

N/A

0DataRank · unranked

35 citations

Jacob B. Allred, Scott M. Schuetze, Elizabeth J. Davis, Michael J. Wagner, Andrew Poklepovic +10 more

Data from Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells

(2023)10.1158/1078-0432.c.6532685.v1

Top 100%

0DataRank

Top 100%0 citations

Laura Riolobos, Bonnie LaFleur, Matthew B. Spraker, Yongwoo David Seo, Kimberly S. Smythe +24 more

Incidence and Presenting Characteristics of Angiosarcoma in the US, 2001-2020

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.6235

N/A

0DataRank · unranked

43 citations

Vinod Ravi, Stephanie K. Schaub, E.Y. Kim, Jeremy Sharib, Harveshp Mogal +11 more

Treatment Access for Gastrointestinal Stromal Tumor in Predominantly Low- and Middle-Income Countries

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.4898

N/A

0DataRank · unranked

5 citations

J. Michael Wrigglesworth, Ines Garcia-Gonzalez, Catherina Scheepers, Mei Ching Ong, Viji Venkatesh +7 more

Incorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug Response

UNC Libraries(2020)10.17615/4119-bx79

N/A

0DataRank · unranked

0 citations

Alison A. Motsinger‐Reif, John B. Buse, Daniel M. Rotroff, Skylar W. Marvel, Hillary Graham +3 more

Early, precise, and safe clinical evaluation of the pharmacodynamic effects of novel agents in the intact human tumor microenvironment

Frontiers in Pharmacology(2024)10.3389/fphar.2024.1367581

N/A

0DataRank · unranked

3 citations

Karthik Rajasekaran, Jeffrey Houlton, Gary B. Deutsch, Thomas J. Ow, Robert G. Maki +29 more

Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial

UNC Libraries(2020)10.17615/6279-bc60

N/A

0DataRank · unranked

0 citations

Jan Skupień, Patinut Buranasupkajorn, Timothy Hastings, Skylar W. Marvel, Hetal Shah +14 more

Immunologic Gene Signature Analysis Correlates Myeloid Cells and M2 Macrophages with Time to Trabectedin Failure in Sarcoma Patients

Cancers(2022)10.3390/cancers14051290

N/A

0DataRank · unranked

11 citations

Yuzheng Zhang, Kimberly S. Smythe, Parth Desai, Anish Thomas, Pedro Viveiros +11 more

Oncogenic role of a developmentally regulated NTRK2 splice variant

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.07.475392

N/A

0DataRank · unranked

0 citations

Sonali Arora, Nicholas Nuechterlein, Michael Zager, Keith R. Loeb, Patrick J. Cimino +13 more

Michael J. Wagner

Indexed papers

Top data-sharing exemplar

Papers